These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Monitoring of renal transplant patients with interleukin-2 and interleukin-2 receptor enzyme immunoassay and interleukin-2 receptor immunocytology. Dittmer R; Harfmann P; Tenschert W; Arndt R; Busch B Transplant Proc; 1990 Oct; 22(5):2284-5. PubMed ID: 2219370 [No Abstract] [Full Text] [Related]
3. Plasma GM-CSF, IL-6, and IL-3 monitoring allows differentiation between infection and rejection in some renal transplant recipients: preliminary results of a retrospective study. Daniel V; Pasker S; Reiss U; Weimer R; Wiesel M; Pomer S; Staehler G; Opelz G Transplant Proc; 1993 Feb; 25(1 Pt 2):893-6. PubMed ID: 8382882 [No Abstract] [Full Text] [Related]
4. Evaluation of serum immunological parameters in acute renal allograft rejection. Yang J; Li XW; Zheng FL; Bi ZQ Transplant Proc; 1996 Jun; 28(3):1443-4. PubMed ID: 8658732 [No Abstract] [Full Text] [Related]
5. Plasma soluble interleukin-2 receptor (IL-2RS) level and activation markers in blood in the follow-up of renal allograft patients. Malcus C; Pouteil-Noble C; Touraine F; Raffaele P; Touraine JL Transplant Proc; 1990 Aug; 22(4):1865-6. PubMed ID: 2389463 [No Abstract] [Full Text] [Related]
6. Interleukin-2 receptor positive cell levels in cyclosporin-versus azathioprine-treated renal transplant patients. Möhring K; Pomer S; Daniel U; Rambausek M Transplant Proc; 1989 Feb; 21(1 Pt 2):1469. PubMed ID: 2652470 [No Abstract] [Full Text] [Related]
7. The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients. Kutukculer N; Clark K; Rigg KM; Forsythe JL; Proud G; Taylor RM; Shenton BK Transplantation; 1995 Feb; 59(3):333-40. PubMed ID: 7871561 [TBL] [Abstract][Full Text] [Related]
8. Soluble interleukin 2 receptor level in liver allograft recipients: an indicator of rejection. Perkins JD; Nelson DL; Rakela J; Grambsch PM; Krom RA Transplant Proc; 1989 Feb; 21(1 Pt 2):2275-6. PubMed ID: 2540568 [No Abstract] [Full Text] [Related]
9. Serial monitoring shows plasma protein C and free protein S levels are decreased during human acute renal allograft rejection. Tsuchida A; Thomson NM; Salem HH; Atkins RC; Hancock WW Transplant Proc; 1990 Oct; 22(5):2134-6. PubMed ID: 2145671 [No Abstract] [Full Text] [Related]
11. Plasma alpha-2 glycomicroglobulin in monitoring allograft function and in predicting rejection episodes in kidney transplantation (preliminary results). Ayatse JO Acta Med Hung; 1989; 46(4):315-22. PubMed ID: 2636365 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 measurements in peripheral blood after kidney transplantation. Albert FW; Schmidt U; Seyfert UT; Würmell W; Gümbel W Transplant Proc; 1990 Aug; 22(4):1852-3. PubMed ID: 2389459 [No Abstract] [Full Text] [Related]
13. Monitoring of renal allograft rejection with fine needle aspiration biopsy and serum C-reactive protein determinations. Kaden J; Strobelt V; Oesterwitz H; Groth J; May G; Eichler C Transplant Proc; 1987 Feb; 19(1 Pt 2):1657. PubMed ID: 3274398 [No Abstract] [Full Text] [Related]
14. A critical analysis of serum and urine interleukin 2 receptor assays in renal allograft recipients. Colvin RB; Preffer FI; Fuller T; Brown M; Ip S; Kung P; Cosimi AB Transplant Proc; 1989 Feb; 21(1 Pt 2):1863. PubMed ID: 2652605 [No Abstract] [Full Text] [Related]
15. Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients. George JF; Kirklin JK; Naftel DC; Bourge RC; White-Williams C; McGiffin DC; Savunen T; Everson MP J Heart Lung Transplant; 1997 Oct; 16(10):1046-53. PubMed ID: 9361247 [TBL] [Abstract][Full Text] [Related]